Founded in 2007, Y-Biologics is a renowned
in South Korea for its expertise in
antibody science. Since its foundation, we have dedicated ourselves to the discovery & development of novel antibody therapeutics.
By utilizing our two platform technologies Y-max ABLTM & ALiCETM in R&D process, we aim to be a leading
biopharmaceutical company in fields of immuno-oncology.